| ALR | Abuse Liability Rating |
| BAI | Beck Anxiety Inventory |
| BDI | Beck Depression Inventory |
| BID | Twice daily |
| BVRT | Benton Visual Retention Test |
| CBD | Cannabidiol |
| COWAT | Controlled Oral Word Association Test |
| CW | Charlotte’s Web |
| D9-THC | Delta-9-tetryhydrocannabinol |
| GC-MS | Gas chromatography-mass spectrometry |
| HAM-A | Hamilton Anxiety Rating Scale |
| LC | Liquid chromatography |
| LMM | Linear mixed model |
| LNS | Letter-Number Sequencing |
| MC | Medical cannabis |
| MCT | Medium chain triglyceride |
| MSIT | Multi-Source Interference Test |
| OASIS | Overall Anxiety Severity and Impairment Scale |
| PANAS | Positive and Negative Affect Scale |
| PGIC | Patient’s Global Impression of Change |
| POMS | Profile of Mood States |
| PSQI | Pittsburgh Sleep Quality Index |
| RAVLT | Rey Auditory Verbal Learning Test |
| SAD | Social anxiety disorder |
| SCID | Structured Clinical Interview—DSM-5 |
| SEQ | Side Effects Questionnaire |
| SF-36 | Medical Outcomes Study Questionnaire Short Form 36 Item |
| SPST | Simulated public speaking test |
| SSRI | Selective serotonin reuptake inhibitor |
| STAI | State-Trait Anxiety Inventory |
| TID | Three times per day |
| TMD | Total Mood Disturbance |
| TMT | Trail Making Test |
| U.S. | United States |
| WAIS-R | Wechsler Adult Intelligence Scale-Revised |
| WASI-II | Wechsler Abbreviated Scale of Intelligence—II |